Abstract:CRISPR systems have been proven as versatile tools for site-specific genome engineering in mammalian species. During the gene editing processes, these RNA-guide nucleases introduce DNA double strand breaks (DSBs), in which non-homologous DNA end joining (NHEJ) dominates the DNA repair pathway, limiting the efficiency of homology-directed repair (HDR), the alternative pathway essential for precise gene targeting. Multiple approaches have been developed to enhance HDR, including chemical compound or RNA interference-mediated inhibition of NHEJ factors, small molecule activation of HDR enzymes, or cell cycle timed delivery of CRISPR complex. However, these approaches face multiple challenges, yet have moderate or variable effects. Here we developed a new approach that programs both NHEJ and HDR pathways with CRISPR activation and interference (CRISPRa/i) to achieve significantly enhanced HDR efficiency of CRISPR-mediated gene editing. The manipulation of NHEJ and HDR pathway components, such as CtIP, CDK1, KU70, KU80, and LIG4, was mediated by catalytically dead guide RNAs (dgRNAs), thus relying on only a single catalytically active Cas9 to perform both CRISPRa/i and precise gene editing. While reprogramming of most DNA repair factors or their combinations tested enhanced HDR efficiency, simultaneously activating CDK1 and repressing KU80 has the strongest effect with increased HDR rate upto an order of magnitude. Doxycycline-induced dgRNA-based CRISPRa/i programming of DNA repair enzymes, as well as viral packaging enabled flexible and tunable HDR enhancement for broader applicability in mammalian cells. Our study provides an effective, flexible, and potentially safer strategy to enhance precise genome modifications, which might broadly impact human gene editing and therapy.

PAM recognition by miniature CRISPR-Cas14 triggers programmable double-stranded DNA cleavage

PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes

Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Programmable DNA Repair with CRISPRa/i Enhanced Homology-Directed Repair Efficiency with a Single Cas9

Innate programmable DNA binding by CRISPR-Cas12m effectors enable efficient base editing

DNA interrogation by the CRISPR RNA-guided endonuclease Cas9

Programmed genome editing by a miniature CRISPR-Cas12f nuclease

A small PAM optimises target recognition in the CRISPR-Cas immune system

Compact SchCas9 Recognizes the Simple NNGR PAM

DNA targeting by compact Cas9d and its resurrected ancestor

Efficient Cleavage Resolves PAM Preferences of CRISPR-Cas in Human Cells.

Molecular Basis and Engineering of Miniature Cas12f with C-rich PAM Specificity

PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9

Rapid two-step target capture ensures efficient CRISPR-Cas9-guided genome editing

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

An alpha-helical lid guides the target DNA toward catalysis in CRISPR-Cas12a

Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9

DNA topology regulates PAM-Cas9 interaction and DNA unwinding to enable near-PAMless cleavage by thermophilic Cas9